The field of cellular and infection microbiology is being transformed by the integration of traditional medical approaches, advanced antimicrobial ...
SEATTLE – September 23, 2025 – A coalition of leading infectious disease and cancer experts is urging for the creation of a clinical trials network to evaluate the safety and efficacy of existing and ...
Updated IDSA/PIDS guidelines for 2026 provide recommendations for managing CAP-associated parapneumonic effusion in children.
Vedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointestinal diseases, today announced a poster presentation related to the ...
The COVID-19 pandemic, along with advancements in new therapeutics and mRNA vaccines, has further intensified the need for knowledgeable professionals in the fields of immunology, microbiology, and ...
Please provide your email address to receive an email when new articles are posted on . Clinical Infectious Diseases has launched an article series looking in-depth at real cases and the clinical ...
CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...
Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, intends to present a full suite of preclinical findings from the company’s lead candidate, ...
Researchers in the UC Davis Department of Pathology and Laboratory Medicine have created a new tuberculosis blood test that ...
Infectious diseases shape health care in complex ways, impacting research, treatment and public health — locally and globally. The capability of infectious agents to rapidly adapt to host defenses is ...
The Fundamental Concepts in Infectious Disease post-baccalaureate certificate program enhances critical thinking and problem-solving skills used to explore human pathogens and the molecular mechanisms ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results